Literature DB >> 19085895

A dedicated vascular access program can improve arteriovenous fistula rates without increasing catheters.

M Kiaii1, J M MacRae.   

Abstract

PURPOSE: We describe the development and implementation of a comprehensive multidisciplinary vascular access (VA) program and describe its impact on VA distribution rates.
METHODS: A retrospective review of all incident and prevalent patients in our hemodialysis (HD) unit was conducted in September 2001 to determine baseline data including: type of VA along with patient characteristics and comorbidities. Similar data was extracted from the database in 2005 for incident and prevalent patients.
RESULTS: The VA program had a significant impact on arteriovenous fistulae (AVF) rates in both incident and prevalent HD patients: incident AVF rates increased from 14 to 39% (p=0.04) and prevalent AVF rates from 60 to 64% (p=0.015). Multivariate analysis revealed that male gender (OR 1.79 [CI 0.85-0.98, p=0.006]) and year of dialysis initiation 2005 vs. 2001 (OR 1.65 [CI 1.09-2.5, p=0.017]) were associated with AVF use among prevalent HD patients. Furthermore, age (per 5 years over 70) is associated with a decreased likelihood of having an AVF (OR 0.91 [CI 0.85-0.98, p=0.009]) whereas comorbidities of cardiovascular disease and diabetes had no impact.
CONCLUSION: We demonstrate that a structured VA program can increase the number of functioning fistulas without a corresponding increase in catheters in incident and prevalent HD patients.

Entities:  

Mesh:

Year:  2008        PMID: 19085895

Source DB:  PubMed          Journal:  J Vasc Access        ISSN: 1129-7298            Impact factor:   2.283


  8 in total

Review 1.  New Insights into Dialysis Vascular Access: What Is the Optimal Vascular Access Type and Timing of Access Creation in CKD and Dialysis Patients?

Authors:  Karen Woo; Charmaine E Lok
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-11       Impact factor: 8.237

Review 2.  The importance of success prediction in angioaccess surgery.

Authors:  Branko Fila; Saša Magaš; Predrag Pavić; Renata Ivanac; Marko Ajduk; Marko Malovrh
Journal:  Int Urol Nephrol       Date:  2016-05-18       Impact factor: 2.370

3.  Multi-Disciplinary Vascular Access Care and Access Outcomes in People Starting Hemodialysis Therapy.

Authors:  Simardeep Gill; Robert Quinn; Matthew Oliver; Fareed Kamar; Rameez Kabani; Daniel Devoe; Priyanka Mysore; Neesh Pannu; Jennifer MacRae; Braden Manns; Brenda Hemmelgarn; Matthew James; Marcello Tonelli; Adriane Lewin; Ping Liu; Pietro Ravani
Journal:  Clin J Am Soc Nephrol       Date:  2017-09-14       Impact factor: 8.237

4.  Arteriovenous fistulas among incident hemodialysis patients in Department of Defense and Veterans Affairs facilities.

Authors:  Frank P Hurst; Kevin C Abbott; Dominic Raj; Mahesh Krishnan; Carlos E Palant; Lawrence Y Agodoa; Rahul M Jindal
Journal:  J Am Soc Nephrol       Date:  2010-08-12       Impact factor: 10.121

Review 5.  New Frontiers in Vascular Access Practice: From Standardized to Patient-tailored Care and Shared Decision Making.

Authors:  Mariana Murea; Karen Woo
Journal:  Kidney360       Date:  2021-06-15

6.  Stakeholder-Guided Development of Dialysis Vascular Access Education Materials.

Authors:  Adeline Dorough; Julia H Narendra; Caroline Wilkie; Akhil Hegde; Kawan Swain; Emily H Chang; Terence Oliver; Jennifer E Flythe
Journal:  Kidney360       Date:  2021-05-03

7.  Targeting Patient and Health System Barriers To Improve Rates of Hemodialysis Initiation with an Arteriovenous Access.

Authors:  Jennifer E Flythe; Julia H Narendra; Christina Yule; Surya Manivannan; Shannon Murphy; Shoou-Yih D Lee; Tara S Strigo; Sarah Peskoe; Jane F Pendergast; L Ebony Boulware; Jamie A Green
Journal:  Kidney360       Date:  2021-02-26

8.  Relationships Between Clinical Processes and Arteriovenous Fistula Cannulation and Maturation: A Multicenter Prospective Cohort Study.

Authors:  Michael Allon; Peter B Imrey; Alfred K Cheung; Milena Radeva; Charles E Alpers; Gerald J Beck; Laura M Dember; Alik Farber; Tom Greene; Jonathan Himmelfarb; Thomas S Huber; James S Kaufman; John W Kusek; Prabir Roy-Chaudhury; Michelle L Robbin; Miguel A Vazquez; Harold I Feldman
Journal:  Am J Kidney Dis       Date:  2018-02-02       Impact factor: 8.860

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.